267 related articles for article (PubMed ID: 19705417)
1. Mind-body complementary alternative medicine use and quality of life in adolescents with inflammatory bowel disease.
Cotton S; Humenay Roberts Y; Tsevat J; Britto MT; Succop P; McGrady ME; Yi MS
Inflamm Bowel Dis; 2010 Mar; 16(3):501-6. PubMed ID: 19705417
[TBL] [Abstract][Full Text] [Related]
2. The experiences of persons living with HIV who participate in mind-body and energy therapies: a systematic review protocol of qualitative evidence.
Bremner M; Blake B; Stiles C
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):41-9. PubMed ID: 26571281
[TBL] [Abstract][Full Text] [Related]
3. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL
JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607
[TBL] [Abstract][Full Text] [Related]
4. Yoga as adjunct therapy for adolescents with inflammatory bowel disease: A pilot clinical trial.
Arruda JM; Bogetz AL; Vellanki S; Wren A; Yeh AM
Complement Ther Med; 2018 Dec; 41():99-104. PubMed ID: 30477870
[TBL] [Abstract][Full Text] [Related]
5. Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis.
Nousiainen P; Merras-Salmio L; Aalto K; Kolho KL
BMC Complement Altern Med; 2014 Apr; 14():124. PubMed ID: 24708564
[TBL] [Abstract][Full Text] [Related]
6. Classification of CAM use and its correlates in patients with early-stage breast cancer.
Saquib J; Madlensky L; Kealey S; Saquib N; Natarajan L; Newman VA; Patterson RE; Pierce JP
Integr Cancer Ther; 2011 Jun; 10(2):138-47. PubMed ID: 21382963
[TBL] [Abstract][Full Text] [Related]
7. Use of complementary therapies by patients with IBD may indicate psychosocial distress.
Langmead L; Chitnis M; Rampton DS
Inflamm Bowel Dis; 2002 May; 8(3):174-9. PubMed ID: 11979137
[TBL] [Abstract][Full Text] [Related]
8. Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study.
Habermann TM; Thompson CA; LaPlant BR; Bauer BA; Janney CA; Clark MM; Rummans TA; Maurer MJ; Sloan JA; Geyer SM; Cerhan JR
Am J Hematol; 2009 Dec; 84(12):795-8. PubMed ID: 19894247
[TBL] [Abstract][Full Text] [Related]
9. Complementary and alternative medicine use at a single pediatric inflammatory bowel disease center.
Ceballos C; Bao R; Dunkin D; Song Y; Li XM; Benkov K
Gastroenterol Nurs; 2014; 37(4):265-71. PubMed ID: 25078040
[TBL] [Abstract][Full Text] [Related]
10. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
Gerbarg PL; Jacob VE; Stevens L; Bosworth BP; Chabouni F; DeFilippis EM; Warren R; Trivellas M; Patel PV; Webb CD; Harbus MD; Christos PJ; Brown RP; Scherl EJ
Inflamm Bowel Dis; 2015 Dec; 21(12):2886-96. PubMed ID: 26426148
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and 20-year trends in meditation, yoga, guided imagery and progressive relaxation use among US adults from 2002 to 2022.
Davies JN; Faschinger A; Galante J; Van Dam NT
Sci Rep; 2024 Jul; 14(1):14987. PubMed ID: 38951149
[TBL] [Abstract][Full Text] [Related]
13. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Disease.
Phatak UP; Alper A; Pashankar DS
J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):157-160. PubMed ID: 30499887
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric symptoms and the use of complementary and alternative medicine.
Purohit MP; Wells RE; Zafonte RD; Davis RB; Phillips RS
PM R; 2013 Jan; 5(1):24-31. PubMed ID: 23098832
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
[TBL] [Abstract][Full Text] [Related]
16. Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.
Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
World J Gastroenterol; 2015 Mar; 21(12):3663-70. PubMed ID: 25834335
[TBL] [Abstract][Full Text] [Related]
17. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
[TBL] [Abstract][Full Text] [Related]
18. Mind-body interventions in oncology.
Carlson LE; Bultz BD
Curr Treat Options Oncol; 2008 Jun; 9(2-3):127-34. PubMed ID: 18704692
[TBL] [Abstract][Full Text] [Related]
19. Use of complementary and alternative medicine during pregnancy and the postpartum period: an analysis of the National Health Interview Survey.
Birdee GS; Kemper KJ; Rothman R; Gardiner P
J Womens Health (Larchmt); 2014 Oct; 23(10):824-9. PubMed ID: 25268759
[TBL] [Abstract][Full Text] [Related]
20. Use of mind-body medical therapies.
Wolsko PM; Eisenberg DM; Davis RB; Phillips RS
J Gen Intern Med; 2004 Jan; 19(1):43-50. PubMed ID: 14748859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
